China Pneumonia Outbreak Spurs WHO Action as Mystery Lingers
A mysterious lung infection in the central Chinese city of Wuhan is being monitored by the World Health Organization, which said it’s...
Ikigai: The Japanese secret to living a long and more fulfilling...
For Japanese workers in big cities, a typical work day begins with a state called sushi-zume, a term which likens commuters squeezed into...
Air pollution now linked to brain cancer
New research has linked air pollution nanoparticles to brain cancer for the first time.
The ultra-fine particles (UFPs) are...
A $21,000 hospital bill for five days of psychiatric care? Now...
Arline Feilen lost her husband to suicide in 2013. Three years later, she lost her dad to cancer. And this February, she lost her...
7 Ways to prevent or even reverse heart disease with nutrition
Considering that heart disease is the #1 cause of death in the developed world, anything that can prevent or reduce cardiac mortality, or slow...
Big pharma’s push to oversell ADHD meds to make you feel...
Conditions like ADHD give big pharma many opportunities to sell products that don't heal people but make them feel less stressed about...
Cleansing of the brain affected by breathing
Our brains are washed by a constant flow of cerebrospinal fluid, which plays the important role of carrying away waste substances, such...
Study Links Fluoridated Water to Lower IQs…
An influential medical journal published a study Monday that links fluoride consumption during pregnancy with lower childhood IQs—a finding that could undermine decades of...
Cancer patients cautious on drug that reprograms immune systems to fight...
In a groundbreaking treatment, cancer patients’ immune systems are being genetically reprogrammed to fight their terminal cancer for them, with promising results.
Novartis praised for being ‘responsible’ after setting muscular atrophy medicine at...
The US Food and Drug Administration on Friday approved Novartis’ $2.1 million gene therapy for spinal muscular atrophy — making it the world’s most...